Pancreatic alpha cell mass in European subjects with type 2 diabetes
Authors:
Open Access
- 5 April 2011
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 54 (7) , 1720-1725
Abstract
Aims/hypothesis Type 2 diabetes is a bi-hormonal disease characterised by relative hypoinsulinaemia and hyperglucagonaemia with elevated blood glucose levels. Besides pancreatic beta cell defects, a low number of beta cells (low beta cell mass) may contribute to the insufficient secretion of insulin. In this study our aim was to determine whether the alpha cell mass is also altered. Methods Using a point counting method, we measured the ratio of alpha to beta cell areas in pancreas samples obtained at autopsy from 50 type 2 diabetic subjects, whose beta cell mass had previously been found to be 36% lower than that of 52 non-diabetic subjects. Results The topography of alpha and beta cells was similar in both groups: many alpha cells were localised in the centre of the islets and the ratio of alpha/beta cell areas increased with islet size. The average ratio was significantly higher in type 2 diabetic subjects (0.72) than in non-diabetic subjects (0.42), with, however, a large overlap between the two groups. In contrast, the alpha cell mass was virtually identical in type 2 diabetic subjects (366 mg) and non-diabetic subjects (342 mg), and was not influenced by sex, BMI or type of diabetes treatment. Conclusions The higher proportion of alpha to beta cells in the islets of some type 2 diabetic subjects is due to a decrease in beta cell number rather than an increase in alpha cell number. This imbalance may contribute to alterations in the normal inhibitory influence exerted by beta cells on alpha cells, and lead to the relative hyperglucagonaemia observed in type 2 diabetes.Keywords
This publication has 26 references indexed in Scilit:
- Paracrinology of islets and the paracrinopathy of diabetesProceedings of the National Academy of Sciences, 2010
- Unique Arrangement of α- and β-Cells in Human Islets of LangerhansDiabetes, 2010
- No mantle formation in rodent islets—The prototype of islet revisitedDiabetes Research and Clinical Practice, 2009
- The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormalityDiabetologia, 2009
- Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetesJournal of Endocrinology, 2008
- Distribution of Pancreatic Endocrine Cells Including IAPP-expressing Cells in Non-diabetic and Type 2 Diabetic CasesJournal of Histochemistry & Cytochemistry, 2007
- Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal MicroscopyJournal of Histochemistry & Cytochemistry, 2005
- Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus RevisitedPathology and Immunopathology Research, 1985
- Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humansDiabetes, 1982
- THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUSThe Lancet, 1975